Despite these efforts, only a few genetic changes, including the amplification and/or overexpression of MET and ERBB2 [3], as well as the mutations and downregulation of APC [4] and RUNX3 [5], have been associated with gastric cancer and the underlying molecular mechanisms remain largely undefined. The gene discussed is MET; the disease is gastric cancer.